STEGLUJAN 5 mg/1

STEGLUJAN 5 mg/1 combines ertugliflozin and sitagliptin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

STEGLUJAN 5 mg/1 is designed to help manage type 2 diabetes by improving blood sugar levels. It combines two active ingredients, ertugliflozin and sitagliptin, which work together to support glucose regulation. This medication is typically used alongside diet and exercise to enhance overall diabetes management. People often ask, 'What is STEGLUJAN used for?'—it's primarily for controlling blood sugar in adults with type 2 diabetes.

Common effects of STEGLUJAN 5 mg/1 may include urinary tract infections, symptoms of the common cold, and diarrhea. Some individuals might experience increased urination or mild gastrointestinal discomfort. These effects can vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

STEGLUJAN 5 mg/1 should be handled with care, especially for those with a history of kidney issues or pancreatitis. It's important to stay hydrated while taking this medication. Always follow the guidance of a healthcare professional regarding its use and monitor for any unusual symptoms.

STEGLUJAN 5 mg/1 may interact with certain medications, including insulin and other diabetes treatments. Alcohol consumption should be moderated, as it can affect blood sugar levels. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.